Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
life sciences
national blog main
acute hepatic porphyria
alnylam pharmaceuticals
blackstone
boston
boston blog main
boston top stories
cardiometabolic disorders
clinical trials
europe blog main
europe top stories
fda
givosiran
hereditary transthyretin amyloidosis
inclisiran
investing
jeff poulton
john maraganore
lumasiran
national
national top stories
novartis
oncology
patisiran
pcsk9 inhibitors
primary hyperoxaluria type 1
private equirty
rare disease
regeneron
roche
san francisco
san francisco blog main
sanofi
the medicines company
vutrisiran
What
drugs
2
×
million
pays
2
×
pharmaceuticals
2
×
ago
alnylam
amunix
blackstone
cash
company’s
develop
discover
drug
extension
gaining
grab
half
inclisiran
life
milestone
new
outside
pay
pharma’s
potential
preclinical
proprietary
rights
rnai
roche
seven
sold
stake
tech
technology
upfront
use
years
Language
unset
Current search:
pharmaceuticals
×
drugs
×
pays
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}